SUPERNUS PHARMACEUTICALS, INC.·4

Mar 3, 4:12 PM ET

Khattar Jack A. 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-28
Khattar Jack A.
DirectorPresident, CEO
Transactions
  • Award

    Performance Share Unit

    [F1]
    2026-02-28+38,64038,640 total
    Exercise: $0.00Common Stock (38,640 underlying)
Footnotes (1)
  • [F1]On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.
Signature
/s/ Timothy C. Dec, as attorney-in-fact|2026-03-03

Documents

1 file
  • 4
    wk-form4_1772572321.xmlPrimary

    FORM 4